Ketamine New Zealand - engelsk - Medsafe (Medicines Safety Authority)

ketamine

biomed limited - ketamine hydrochloride 2.307 mg/ml equivalent to 2 mg/ml ketamine - solution for infusion - 2 mg/ml - active: ketamine hydrochloride 2.307 mg/ml equivalent to 2 mg/ml ketamine excipient: sodium chloride water for injection - ketamine infusion is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Ketamine New Zealand - engelsk - Medsafe (Medicines Safety Authority)

ketamine

biomed limited - ketamine hydrochloride 4.613 mg/ml equivalent to 4 mg/ml ketamine - solution for infusion - 4 mg/ml - active: ketamine hydrochloride 4.613 mg/ml equivalent to 4 mg/ml ketamine excipient: sodium chloride water for injection - ketamine infusion is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Ketamine hydrochloride Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ketamine hydrochloride

mavlab pty. ltd. - ketamine hydrochloride - unknown - ketamine hydrochloride anaesthetic active 0.0 - active constituent

KETAMINE HYDROCHLORIDE Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ketamine hydrochloride

ceva animal health pty ltd - ketamine hydrochloride - unknown - ketamine hydrochloride anaesthetic active 0.0 - active constituent

KETAMINE INJECTION, BP SOLUTION Canada - engelsk - Health Canada

ketamine injection, bp solution

baxter corporation - ketamine (ketamine hydrochloride) - solution - 50mg - ketamine (ketamine hydrochloride) 50mg

KETAMINE INJECTION, BP SOLUTION Canada - engelsk - Health Canada

ketamine injection, bp solution

sterimax inc - ketamine (ketamine hydrochloride) - solution - 50mg - ketamine (ketamine hydrochloride) 50mg

KETAJECT ketamine hydrochloride injection solution USA - engelsk - NLM (National Library of Medicine)

ketaject ketamine hydrochloride injection solution

clipper distributing company, llc - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine 100 mg in 1 ml

KETAVED ketamine hydrochloride injection solution USA - engelsk - NLM (National Library of Medicine)

ketaved ketamine hydrochloride injection solution

vedco inc. - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine 100 mg in 1 ml

SPRAVATO- esketamine hydrochloride solution USA - engelsk - NLM (National Library of Medicine)

spravato- esketamine hydrochloride solution

janssen pharmaceuticals inc. - esketamine hydrochloride (unii: l8p1h35p2z) (esketamine - unii:50lfg02txd) - spravato ® is indicated, in conjunction with an oral antidepressant, for the treatment of: - treatment-resistant depression (trd) in adults - depressive symptoms in adults with major depressive disorder (mdd) with acute suicidal ideation or behavior limitations of use: - the effectiveness of spravato in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated [see clinical studies (14.2)] . use of spravato does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of spravato. - spravato is not approved as an anesthetic agent. the safety and effectiveness of spravato as an anesthetic agent have not been established. spravato is contraindicated in patients with: - aneurysmal vascular disease (including thoracic and abdominal aorta, intracranial, and peripheral arterial vessels) or arteriovenous malformation [see warnings and precautions (5.7)] - history of intracere